Edition:
United States

Edwards Lifesciences Corp (EW)

EW on New York Consolidated

92.67USD
21 Feb 2017
Change (% chg)

$2.93 (+3.26%)
Prev Close
$89.74
Open
$93.49
Day's High
$94.29
Day's Low
$92.24
Volume
3,732,152
Avg. Vol
2,520,269
52-wk High
$121.75
52-wk Low
$81.12

EW

Chart for EW

About

Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company manufactures heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. It develops hemodynamic monitoring systems used to measure a... (more)

Overall

Beta: 0.59
Market Cap(Mil.): $19,691.99
Shares Outstanding(Mil.): 212.50
Dividend: --
Yield (%): --

Financials

  EW Industry Sector
P/E (TTM): 35.45 52.89 29.35
EPS (TTM): 2.61 -- --
ROI: 15.07 7.57 12.97
ROE: 22.24 11.40 14.11

Edwards Lifesciences fourth-quarter sales, profit top expectations

Edwards Lifesciences Corp on Wednesday reported higher-than-expected fourth-quarter profit and revenue on surging demand for its minimally invasive heart valve replacement systems.

Feb 01 2017

Edwards Lifesciences 4th-quarter sales, profit top expectations

Feb 1 Edwards Lifesciences Corp on Wednesday reported higher-than-expected fourth-quarter profit and revenue on surging demand for its minimally invasive heart valve replacement systems.

Feb 01 2017

BRIEF-Edwards Lifesciences Corp Q4 EPS $0.73

* Q4 global transcatheter heart valve therapy sales up 29 percent to $432 million

Feb 01 2017

Edwards wins more than $20 million in interest in heart valve dispute

A federal judge in Boston awarded Edwards Lifesciences Corp $20.7 million in prejudgment interest on top of the $91 million it already won in a trade secret lawsuit against rival Neovasc Inc, bringing the total to more than $111 million.

Jan 19 2017

Edwards Lifesciences to buy Israel's Valtech for up to $690 million

JERUSALEM Edwards Lifesciences Corp on Monday said it has agreed to buy Israel's Valtech Cardio for $340 million in stock and cash, with the potential for an additional $350 million in pre-specified milestone-driven payments over the next 10 years.

Nov 28 2016

UPDATE 1-Edwards Lifesciences to buy Israel's Valtech for up to $690 mln

JERUSALEM, Nov 28 Edwards Lifesciences Corp on Monday said it has agreed to buy Israel's Valtech Cardio for $340 million in stock and cash, with the potential for an additional $350 million in pre-specified milestone-driven payments over the next 10 years.

Nov 28 2016

Edwards Lifesciences to buy Israel's Valtech for up to $690 mln

JERUSALEM, Nov 28 Edwards Lifesciences Corp on Monday said it has agreed to buy Israel's Valtech Cardio for $340 million in stock and cash, with the potential for an additional $350 million in pre-specified milestone-driven payments over the next 10 years.

Nov 28 2016

BRIEF-Edwards enters into agreement to acquire Valtech Cardio

* Purchase price of Valtech is $340 million in stock and cash at closing,

Nov 28 2016

Edwards wins $21 mln in enhanced damages in heart valve trade secrets case

A federal judge in Boston has ordered medical device maker Neovasc Inc to pay an extra $21 million in enhanced damages on top of a $70 million jury verdict in a trade secret lawsuit filed by a former client.

Oct 31 2016

Earnings in focus as Apple weighs; Boeing lifts Dow

Quarterly results were the main driver for Wall Street on Wednesday as a decline in Apple shares weighed on the S&P 500 and Nasdaq, while the price-weighted Dow Industrials was buoyed by gains in Boeing. | Video

Oct 26 2016

More From Around the Web

Earnings vs. Estimates